Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303-Reference-Cited by-同舟云学术

Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303

Published:2011-09 Issue:9 Volume:17 Page:1343-1351
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Devine Steven M.,Carter Shelly,Soiffer Robert J.,Pasquini Marcelo C.,Hari Parameswaran N.,Stein Anthony,Lazarus Hillard M.,Linker Charles,Stadtmauer Edward A.,Alyea Edwin P.,Keever-Taylor Carolyn A.,O’Reilly Richard J.

Funder

National Heart, Lung, and Blood Institute and the National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. Hematopoietic stem-cell transplantation;Copelan;N Engl J Med,2006

2. Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?;Cornelissen;Blood,2007

3. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials;Koreth;JAMA,2009

4. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study;Slovak;Blood,2000

5. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial;Suciu;Blood,2003

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation;Pediatric Hematology/Oncology and Immunopathology;2024-07-22

2. Shape of the art: TCR-repertoire after allogeneic hematopoietic cell transplantation;Best Practice & Research Clinical Haematology;2024-06

3. The rationale behind grafting haploidentical hematopoietic stem cells;Hematology;2024-05-07

4. Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients;Cytotherapy;2024-04

5. Hematopoietic Cell Collection;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024